В. Моисеенко

3.2k total citations
53 papers, 304 citations indexed

About

В. Моисеенко is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, В. Моисеенко has authored 53 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in В. Моисеенко's work include Cancer Immunotherapy and Biomarkers (7 papers), Advanced Radiotherapy Techniques (6 papers) and Lung Cancer Treatments and Mutations (5 papers). В. Моисеенко is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Advanced Radiotherapy Techniques (6 papers) and Lung Cancer Treatments and Mutations (5 papers). В. Моисеенко collaborates with scholars based in Russia, Denmark and United States. В. Моисеенко's co-authors include Semiglazov Vf, В. В. Семиглазов, Alexey Manikhas, О. А. Иванова, В Г Иванов, Светлана Проценко, Per Pfeiffer, Guillem Argilés, Cornelis J.A. Punt and Harpreet Wasan and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

В. Моисеенко

41 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
В. Моисеенко Russia 8 208 64 49 33 33 53 304
Zahir Moloo Kenya 10 152 0.7× 74 1.2× 40 0.8× 30 0.9× 65 2.0× 33 304
Sandro Tognazzo Italy 7 124 0.6× 69 1.1× 40 0.8× 30 0.9× 35 1.1× 13 330
Nirupama Bonthala United States 6 146 0.7× 60 0.9× 27 0.6× 40 1.2× 30 0.9× 21 294
V Nirmala Oman 9 94 0.5× 54 0.8× 71 1.4× 45 1.4× 39 1.2× 27 298
Abhenil Mittal India 9 101 0.5× 88 1.4× 74 1.5× 24 0.7× 65 2.0× 53 325
TVSVGK Tilak India 9 97 0.5× 35 0.5× 54 1.1× 19 0.6× 41 1.2× 33 307
Iara Viana Vidigal Santana Brazil 11 102 0.5× 64 1.0× 77 1.6× 35 1.1× 67 2.0× 33 290
Alberto Ranghiero Italy 12 102 0.5× 87 1.4× 60 1.2× 19 0.6× 67 2.0× 28 296
Alec Kacew United States 12 157 0.8× 33 0.5× 60 1.2× 32 1.0× 46 1.4× 25 400
Emily Shaw United Kingdom 10 134 0.6× 80 1.3× 75 1.5× 59 1.8× 90 2.7× 27 390

Countries citing papers authored by В. Моисеенко

Since Specialization
Citations

This map shows the geographic impact of В. Моисеенко's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by В. Моисеенко with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites В. Моисеенко more than expected).

Fields of papers citing papers by В. Моисеенко

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by В. Моисеенко. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by В. Моисеенко. The network helps show where В. Моисеенко may publish in the future.

Co-authorship network of co-authors of В. Моисеенко

This figure shows the co-authorship network connecting the top 25 collaborators of В. Моисеенко. A scholar is included among the top collaborators of В. Моисеенко based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with В. Моисеенко. В. Моисеенко is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Болотина, Л. В., Lyudmila Zhukova, В. Моисеенко, et al.. (2025). Russian consensus on prevention, diagnosis and treatment of gastric cancer. Systemic therapy issues. Malignant tumours. 15(1). 76–85.
2.
Moiseenko, Fedor, Aram Oganesian, В. Моисеенко, et al.. (2025). Prognostic model integrating histology, systemic inflammation, and recurrence status predicts immunotherapy response in advanced non-small-cell lung cancer patients. Biology Direct. 20(1). 78–78. 1 indexed citations
3.
Моисеенко, В., et al.. (2024). ONONCOPLASTIC SURGERY OF THE BREAST AFTER NEOADJUVANT SYSTEMIC THERAPY. 25(2). 174–181.
4.
Моисеенко, В., et al.. (2022). Практические рекомендации по лечению анемии при злокачественных новообразованиях. Malignant tumours. 12(3s2-2). 19–25. 1 indexed citations
5.
Моисеенко, В., et al.. (2021). Esophageal stenting for unresectable cancer (review of literature). SHILAP Revista de lepidopterología. 179(5). 113–119.
6.
Hofmann, Axel, Matti Aapro, Е Б Жибурт, et al.. (2021). Patient blood management in oncology in the Russian Federation: Resolution to improve oncology care. Journal of Cancer Policy. 31. 100315–100315. 3 indexed citations
7.
Hofmann, Axel, Matti Aapro, Е Б Жибурт, et al.. (2020). Patient blood management in oncology in the Russian Federation: resolution to improve oncology care.. SHILAP Revista de lepidopterología. 22(3). 59–78. 5 indexed citations
8.
Моисеенко, В., et al.. (2020). ESOPHAGEAL STENTING FOR MALIGNANT STENOSIS (three-year outcomes). SHILAP Revista de lepidopterología. 178(6). 23–28.
9.
10.
Lazareva, I., Julia V. Sopova, Maria A. Lebedeva, et al.. (2020). The emergence of hypervirulent blaNDM-1-positive Klebsiella pneumoniae sequence type 395 in an oncology hospital. Infection Genetics and Evolution. 85. 104527–104527. 15 indexed citations
11.
Cutsem, Eric Van, Iwona Danielewicz, Mark Saunders, et al.. (2020). Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study. Annals of Oncology. 31(9). 1160–1168. 40 indexed citations
12.
Моисеенко, В., et al.. (2019). Mineralization of the Peritoneum — a New Target in the Treatment of Peritoneal Carcinomatosis. SHILAP Revista de lepidopterología. 8(4). 279–284.
13.
Moiseenko, Fedor, et al.. (2019). P2.14-30 Predictive Value of ctDNA in Patients with EGFR Positive NSCLC Receiving 3rd Generation TKI. Journal of Thoracic Oncology. 14(10). S841–S841. 1 indexed citations
14.
15.
Moiseenko, Fedor, et al.. (2019). Investigation of the mechanisms of resistance to osimertinib in patients with T790M-associated NSCLC. Annals of Oncology. 30. vii16–vii16. 1 indexed citations
16.
Fedyanin, М. Yu., et al.. (2017). BCD-100 - first russian PD-1 inhibitor. SHILAP Revista de lepidopterología. 3 indexed citations
17.
18.
19.
Моисеенко, В., et al.. (2000). [Treatment with Miltex for metastatic skin lesions in breast cancer] .. PubMed. 46(5). 600–3. 1 indexed citations
20.
Моисеенко, В., et al.. (1998). [Randomized trial of two administration schedule of bonephos (Clodronate) in patients with painful bone metastasis].. PubMed. 44(6). 725–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zahir Moloo Breakdown of academic impact, for papers by Sandro Tognazzo Breakdown of academic impact, for papers by Nirupama Bonthala Breakdown of academic impact, for papers by V Nirmala Breakdown of academic impact, for papers by Abhenil Mittal Breakdown of academic impact, for papers by TVSVGK Tilak Breakdown of academic impact, for papers by Iara Viana Vidigal Santana Breakdown of academic impact, for papers by Alberto Ranghiero Breakdown of academic impact, for papers by Alec Kacew Breakdown of academic impact, for papers by Emily Shaw
Rankless by CCL
2026